Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
Scientists test a library of lipid-based compounds to empower safe RNA drug delivery to Lungs Kumar Jeetendra | July 30, 2021 Japan’s Hokkaido University researchers created and tested a collection of lipid-based compounds in order to deliver RNA drugs safely and effectively to the lungs. The findings were published in Materials Horizons. The COVID-19 pandemic response made it all more familiar with RNA vaccines. These vaccines carry genetic code into the cells, which triggers the production …
Israel to offer third COVID booster shot to older residents Kumar Jeetendra | July 30, 2021 Israels prime minister on Thursday announced that the country would offer a coronavirus booster to people over 60 who have already been vaccinated. The announcement by Naftali Bennett makes Israel the first country to offer a third dose of the Pfizer/BioNtech vaccine to its citizens on a wide scale The decision came at a time …
AstraZeneca to look for US approval of Coronavirus immunization in second half Kumar Jeetendra | July 29, 2021 AstraZeneca said on Thursday that it intends to seek US authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application. The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million …
WHO has started audit process for emergency use listing of Bharat Biotech’s Covaxin: Govt Kumar Jeetendra | July 28, 2021 All documents required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the review process by the agency has commenced, Minister of State for Health Bharati Pravin Pawar told Rajya Sabha on Tuesday. Responding to a question on whether it has come …
Biosimilar Products for Research Use Kumar Jeetendra | July 27, 2021 AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics. Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs …
Brazil scraps Covaxin’s EUA application after Bharat Biotech ends agreement with accomplices Kumar Jeetendra | July 27, 2021 After suspending the proposed clinical trials of Bharat Bioetchs COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian company for the jab. The Brazilian health regulator’s decisioncomesafter the vaccine maker informed the South American country about thetermination of its pact with its partners in that country. According to …
How the Delta variant overturns suppositions about the Covid Kumar Jeetendra | July 26, 2021 The Delta variant is the fastest, fittest and most formidable version of the coronavirus that causes COVID-19 the world has encountered, and it is upending assumptions about the disease even as nations loosen restrictions and open their economies, according to virologists and epidemiologists. Vaccine protection remains very strong against severe infections and hospitalizations caused by …
Should vaccinated personals mask up with COVID-19 cases rising? Kumar Jeetendra | July 23, 2021 It depends on your situation, but masking in public can provide another layer of protection and help prevent the virus from spreading to others who aren’t protected. An easing of safety precautions and the large number of people who remain unvaccinated in many regions are contributing to the spread of cases around the world. The …
New COVID variant ‘likely’ this year: Top French master Kumar Jeetendra | July 23, 2021 The French government’s top advisor on COVID-19 warned Friday that a new variant of the disease would “probably” emerge in the winter months this year. The country is currently battling an unprecedented spike in new cases caused by the more infectious Delta variant, which was first recorded in India. “We will probably have another variant …
Bharat Biotech commits to supply 500 million dosages of Covaxin to Center for vaccination drive Kumar Jeetendra | July 23, 2021 Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based vaccine maker, said the companys facilities in four …
Prevalence of COVID-19’s Delta variant among samples sequenced over recent weeks surpassed 75%: WHO Kumar Jeetendra | July 22, 2021 The prevalence of the highly-transmissible Delta variant of COVID-19 among specimens sequenced over the past four weeks exceeded 75 percent in many countries worldwide, including India, China, Russia, Israel and the UK, the WHO has said. In the COVID-19 Weekly Epidemiological Update published July 20, the World Health Organisation said that despite efforts to extend …
